IP Library Granted Patent US 8,884,100
Granted Patent B2
US 8,884,100 · App. 13/389,815 · Granted Nov 11, 2014

Aromatic prenyltransferase from

Inventors: Jonathan E. Page (Saskatoon, CA); Zakia Boubakir (Saskatoon, CA)
Assignees: National Research Council of Canada; University of Saskatchewan
C12P17/06C12N15/8243C12N9/1085
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,884,100
App. No.
13/389,815
Granted
Nov 11, 2014
Kind
B2
Abstract

Nucleic acid molecules from Cannabis sativa (cannabis, hemp, marijuana) have been isolated and characterized, and encode polypeptides having aromatic prenyltransferase activity. Specifically, the enzyme, CsPT1, is a geranylpyrophosphate olivetolate geranyltransferase, active in the cannabinoid biosynthesis step of prenylation of olivetolic acid to form cannabigerolic acid (CBGA). Expression or over-expression of the nucleic acids alters levels of cannabinoid compounds. The polypeptides may be used in vivo or in vitro to produce cannabinoid compounds.

Claims (12)

1. An isolated or purified nucleic acid molecule comprising a nucleotide sequence as set forth in SEQ ID NO: 1 or a codon degenerate nucleotide sequence thereof that encodes a polypeptide having aromatic prenyltransferase activity.

2. A vector, construct or expression system comprising the nucleic acid molecule as defined in claim 1 .

3. A method of decreasing levels of cannabinoid compounds in a plant of the genus Cannabis or a cell thereof, said method comprising transgenically expressing the nucleic acid molecule as defined in claim 1 , or a part thereof, to silence an aromatic prenyltransferase gene in the plant or cell thereof.

4. A method of increasing levels of cannabinoid compounds in an organism, cell or tissue, said method comprising transgenically expressing or over-expressing the nucleic acid molecule as defined in claim 1 in the organism, cell or tissue.

5. A method of increasing levels of cannabinoid compounds in an organism, cell or tissue, said method comprising transgenically expressing or over-expressing a nucleic acid molecule encoding the polypeptide having the sequence of SEQ ID NO: 2 in the organism, cell or tissue.

6. The method of claim 4 , wherein the organism is a microorganism.

7. The method of claim 6 , wherein the microorganism is yeast or E. coli.

8. The method of claim 5 , wherein the nucleic acid molecule is expressed or over-expressed in combination with expression or over-expression of one or more other nucleic acids that encode one or more enzymes in a cannabinoid biosynthetic pathway.

9. The method of claim 8 , wherein the one or more enzymes in a cannabinoid biosynthetic pathway is one or more of cannabigerolic acid, Δ 9 -tetrahydrocannabinolic acid, cannabidiolic acid, cannabichromenic acid, Δ 9 -tetrahydrocannabinol, cannabidiol, cannabichromene.

10. The method of claim 5 , wherein the organism is a microorganism.

11. The method of claim 10 , wherein the microorganism is yeast or E. coli.

12. An expression vector comprising a nucleic acid molecule expressing a polypeptide having the sequence of SEQ ID NO: 2.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 10, 2026
From: NATIONAL RESEARCH COUNCIL OF CANADA
To: UNIVERSITY OF SASKATCHEWAN
Reel/Frame 074340/0683 →
ASSIGNOR ASSIGNS 50% INTEREST Recorded Oct 7, 2014
From: NATIONAL RESEARCH COUNCIL OF CANADA
To: UNIVERSITY OF SASKATCHEWAN
Reel/Frame 033899/0057 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 24, 2012
From: PAGE, JONATHAN E.; BOUBAKIR, ZAKIA
To: NATIONAL RESEARCH COUNCIL OF CANADA
Reel/Frame 027757/0872 →
Continuity (3)
Provisional Application 61272057 · Aug 12, 2009
Provisional Application 61272117 · Aug 18, 2009
Related Publication 20120144523A1 · Jun 7, 2012